Moderna has agreed to distribute 2.44 million doses of the shots produced by Samsung to South Korea. - AFP
SEOUL (Reuters): South Korea granted emergency use approval for Moderna's Covid-19 vaccine produced by South Korean drugmaker Samsung BioLogics, the health ministry said on Tuesday (Oct 26).
Moderna has agreed to distribute 2.44 million doses of the shots produced by Samsung to South Korea after Samsung's Covid-19 vaccine facility on Monday obtained Good Manufacturing Practice (GMP) certification from the drug safety ministry.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
